Hauptseite > Publikationsdatenbank > Finding our way through the labyrinth of dementia biomarkers > print

001     904298
005     20230123101902.0
024 7 _ |a 10.1007/s00259-021-05301-7
|2 doi
024 7 _ |a 0340-6997
|2 ISSN
024 7 _ |a 1432-105X
|2 ISSN
024 7 _ |a 1619-7070
|2 ISSN
024 7 _ |a 1619-7089
|2 ISSN
024 7 _ |a 33876260
|2 pmid
024 7 _ |a WOS:000641217200002
|2 WOS
037 _ _ |a FZJ-2021-05868
082 _ _ |a 610
100 1 _ |a Chételat, Gaël
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Finding our way through the labyrinth of dementia biomarkers
260 _ _ |a Heidelberg [u.a.]
|c 2021
|b Springer-Verl.
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1668670437_936
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a PostPrint liegt leider nicht vor
536 _ _ |a 5253 - Neuroimaging (POF4-525)
|0 G:(DE-HGF)POF4-5253
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Arbizu, Javier
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Barthel, Henryk
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Garibotto, Valentina
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Lammertsma, Adriaan A.
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Law, Ian
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Morbelli, Silvia
|0 P:(DE-HGF)0
|b 6
700 1 _ |a van de Giessen, Elsmarieke
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Drzezga, Alexander
|0 P:(DE-Juel1)177611
|b 8
773 _ _ |a 10.1007/s00259-021-05301-7
|g Vol. 48, no. 8, p. 2320 - 2324
|0 PERI:(DE-600)2098375-X
|n 8
|p 2320 - 2324
|t European journal of nuclear medicine and molecular imaging
|v 48
|y 2021
|x 0340-6997
856 4 _ |u https://juser.fz-juelich.de/record/904298/files/Ch%C3%A9telat2021_Article_FindingOurWayThroughTheLabyrin.pdf
|y Restricted
909 C O |o oai:juser.fz-juelich.de:904298
|p VDB
910 1 _ |a Normandie Univ, UNICAEN, INSERM, U1237, PhIND "Physiopathology and Imaging of Neurological Disorders", Institut Blood and Brain @ Caen-Normandie, Cyceron, 14000, Caen, France. chetelat@cyceron.fr.
|0 I:(DE-HGF)0
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Department of Nuclear Medicine, University of Navarra Clinic, Pamplona, Spain
|0 I:(DE-HGF)0
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Department of Nuclear Medicine, University Hospital of Leipzig, Leipzig, Germany
|0 I:(DE-HGF)0
|b 2
|6 P:(DE-HGF)0
910 1 _ |a Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospitals and NIMTlab, Geneva University, Geneva, Switzerland
|0 I:(DE-HGF)0
|b 3
|6 P:(DE-HGF)0
910 1 _ |a Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Vrije Universiteit, Amsterdam, The Netherlands.
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
|0 I:(DE-HGF)0
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
|0 I:(DE-HGF)0
|b 5
|6 P:(DE-HGF)0
910 1 _ |a Nuclear Medicine Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy
|0 I:(DE-HGF)0
|b 6
|6 P:(DE-HGF)0
910 1 _ |a AMC Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, Amsterdam, The Netherlands
|0 I:(DE-HGF)0
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)177611
910 1 _ |a Department of Nuclear Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
|0 I:(DE-HGF)0
|b 8
|6 P:(DE-Juel1)177611
910 1 _ |a German Center for Neurodegenerative Diseases (DZNE), Bonn/Köln, Germany
|0 I:(DE-HGF)0
|b 8
|6 P:(DE-Juel1)177611
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5253
|x 0
914 1 _ |y 2022
915 _ _ |a DEAL Springer
|0 StatID:(DE-HGF)3002
|2 StatID
|d 2021-02-02
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-02-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-02-02
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-02-02
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b EUR J NUCL MED MOL I : 2019
|d 2021-02-02
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b EUR J NUCL MED MOL I : 2019
|d 2021-02-02
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-2-20090406
|k INM-2
|l Molekulare Organisation des Gehirns
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)INM-2-20090406
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21